BiotechTube
Oasis Diagnostics

Oasis Diagnostics

Vancouver, United States· Est.
4saliva.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Oasis Diagnostics is a private, commercial-stage company specializing in non-invasive salivary diagnostics. It has developed a proprietary suite of saliva collection and stabilization devices for research and clinical use, alongside distributing specialized genomic test kits in North America. The company operates in the growing point-of-care and liquid biopsy markets, targeting early disease detection and personalized medicine. Its core strategy involves enabling reliable saliva-based testing to improve healthcare accessibility and outcomes.

Diagnostics

Technology Platform

Proprietary suite of oral fluid (saliva) collection, stabilization, and processing devices for DNA, RNA, and protein biomarkers, integrated with a quantitative lateral flow test reader (LIAM).

Opportunities

The growing demand for non-invasive, patient-friendly sampling in decentralized healthcare, remote monitoring, and large-scale screening presents a major opportunity.
Expansion into validated clinical diagnostic assays through the VerOFy platform could significantly increase market share and value capture.

Risk Factors

Slow clinical adoption of saliva as a primary diagnostic fluid and intense competition in the collection device market are key risks.
Successful transition from a collection tools company to a developer of proprietary diagnostic tests carries significant execution and regulatory risk.

Competitive Landscape

Oasis competes with large diagnostic companies (e.g., Salimetrics, OraSure Technologies, Neogen) that offer saliva collection products, as well as numerous smaller startups. Its differentiation lies in its specialized devices for specific biomarkers (RNA, DNA) and its focus on standardization and stabilization. The distribution of ViennaLab tests places it in the pharmacogenomics market against other lab test providers.

More companies in Diagnostics & Precision Medicine →More companies in United States →